One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Lawrence M. Roth, MD, 1936-2023.
Ulbright, Thomas M. MD
doi : 10.1097/PGP.0000000000001021
Volume 43(2) pgs. 109-201 March 2024
TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
Kang, Eun Young M.D.; Terzic, Tatjana M.D.; Ghatage, Prafull M.D.; Woo, Lawrence M.D.; Gorringe, Kylie L. Ph.D.; Karnezis, Anthony N. M.D., Ph.D.; Lee, Cheng H. M.D., Ph.D.; Kobel, Martin M.D.
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
Kendall Bartu, Michaela M.D., Ph.D.; Nemejcova, Kristyna M.D. Ph.D.; Michalkova, Romana Ph.D.; Bui, Quang Hiep M.D.; Drozenova, Jana M.D.; Fabian, Pavel M.D., Ph.D.; Fadare, Oluwole M.D.; Hausnerova, Jitka M.D.; Laco, Jan M.D., Ph.D.; Matej, Radoslav M.D., Ph.D.; Mehes, Gabor M.D., Ph.D.; Safanda, Adam M.D.; Singh, Naveena M.D.; Skapa, Petr M.D., Ph.D.; Spurkova, Zuzana M.D.; Stolnicu, Simona M.D., Ph.D.; Svajdler, Marian M.D., Ph.D.; Lax, Sigurd F. M.D., Ph.D.; McCluggage, W. Glenn M.D.; Dundr, Pavel M.D., Ph.D.
HER2/ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
Smithgall, Marie C. M.D.; Yemelyanova, Anna M.D.; Mathew, Susan Ph.D.; Gogineni, Swarna M.D.; He, Bing M.S.; Zhang, Taotao M.D., Ph.D.; Robinson, Brian D. M.D.; Tu, Jiangling J. M.D. Ph.D.
Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
Bhardwaj, Swati M.B.B.S., M.D.; Banet, Natalie M.D.; Gaston, Emily C. M.D.
Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant [latin sharp s]-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube.
Xu, Jin M.D.; McGregor, Stephanie M. M.D., Ph.D.; Park, Kay J. M.D.; Weisman, Paul S. M.D.
Diagnostic Challenges and Long-term Outcomes of Neuroendocrine Carcinoma of the Cervix: A Case Series.
Lamiman, Kelly M.D.; Wilhelm, Alyeesha B. M.D.; Eyzaguirre, Eduardo M.D.; Richardson, Gwyn M.D., J.D.
Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery.
Martell, Kevin M.D.; McIntyre, John B. Ph.D.; Abedin, Tasnima Ph.D.; Kornaga, Elizabeth N. M.Sc.; Chan, Angela M.Y. M.Sc.; Enwere, Emeka Ph.D.; Kobel, Martin M.D.; Dean, Michelle L. B.Sc.; Phan, Tien M.D.; Ghatage, Prafull M.D.; Lees-Miller, Susan P. Ph.D.; Doll, Corinne M. M.D.
Well-differentiated Squamous Cell Carcinoma With Sarcomatous Differentiation in Patient With a History of Recurrent Verrucous Carcinoma.
Ijaz, Komal M.D.; Johannesen, Eric D.O.; Nguyen T, Van M.D.
"Deciduoid" Change in Uterine Leiomyomas in Pregnancy: Aberrant Expression of Sex Cord Markers Inhibin and Calretinin.
Machuca-Aguado, Jesus M.D.; McCluggage, W. Glenn F.R.C.Path.
Uterine Leiomyosarcoma With Osteoclast-like Giant Cells: Report of 2 Cases and Review of Literature.
Chen, Zhengshan M.D., Ph.D.; Ji, Jianling M.D., M.S.; Yung, Evan M.D.; Martin, Sue Ellen M.D., Ph.D.; Walia, Saloni M.D.
The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
Bicer, Elifnur M.D.; Bese, Tugan M.D.; Tuzun, Deniz Dilan M.D.; Ilvan, Sennur M.D.; Kayan, Basak Ozge M.D.; Demirkiran, Fuat M.D.
p16 Block Type Overexpression, p53 Wild Type Reactivity, and Cervical Involvement do not Always Exclude the Diagnosis of Primary Endometrial Squamous Cell Carcinoma (PESCC).
Fanni, Daniela M.D., Ph.D.; Gerosa, Clara M.D.; Peiretti, Michele M.D., Ph.D.; Mais, Valerio M.D., Ph.D.; Massa, Elena M.D., Ph.D.; Angioni, Stefano M.D., Ph.D.; Faa, Gavino M.D.
